New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
Rev. Soc. Bras. Med. Trop
;
49(1): 130-134, Jan.-Feb. 2016. tab
Article
in English
| LILACS
| ID: lil-776530
ABSTRACT
Abstract New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Acinetobacter
/
Beta-Lactamases
/
Acinetobacter Infections
/
Cross Infection
/
Drug Resistance, Multiple, Bacterial
/
Anti-Bacterial Agents
Limits:
Humans
/
Male
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2016
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade do Sul de Santa Catarina/BR
Similar
MEDLINE
...
LILACS
LIS